Condition
Interstitial Lung Disease (ILD) clinical trials and research
As of November 12, 2026, Find a Trial lists 21 Interstitial Lung Disease (ILD) clinical trials that are recruiting, at sites in 12 countries (most in China (5), United Kingdom (3), United States (2)). 1 was first registered in the last 30 days. By phase: Phase 1 (2), Phase 2 (2), Phase 4 (1). The most active sponsors are Ruijin Hospital (2), Hospital de Granollers (2), China-Japan Friendship Hospital (2). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 21Clinical trials
- 1New in 30 days
- 12Countries
Newest Interstitial Lung Disease (ILD) clinical trials
All recruiting trials (21)
-
Chronic Respiratory Disease Participant Engagement
This study tests whether adults with long-term lung conditions can get comfortable with a clinical trials unit and research team before joining future trials.
-
Photon-counting CT vs standard HRCT to help diagnose IPF and other ILDs
This study tests whether photon-counting CT can improve identifying IPF and other ILDs compared with standard HRCT for patients discussed in multidisciplinary teams.
-
Finger vs. Earlobe Pulse Oximetry During a 6-Minute Walk Test in ILD
This study tests whether finger or earlobe pulse oximetry gives the same oxygen saturation readings during a 6-minute walk in people with interstitial lung disease.
-
Tele-Pulmonary Rehabilitation for Chronic Lung Diseases
This study tests whether a remote tele-rehabilitation program helps people with chronic lung diseases start and stick with pulmonary rehab better than usual center-based care.
-
Breathlessness in respiratory diseases: who feels it and why
This study tests how physiology, psychology, function, and breathing patterns relate to breathlessness in people with respiratory conditions compared with healthy controls.
-
Non-invasive tests to help ILD diagnosis and prognosis in pigeon fanciers and ILD patients
Aims to see if easy blood and breath tests can help diagnose and predict outcomes for interstitial lung disease, starting with pigeon fanciers at risk and then extending to ILD patients.
-
Robotic-assisted versus conventional bronchoscopy for cryobiopsy to diagnose interstitial lung disease
This trial will test whether robotic-assisted bronchoscopy with cone-beam CT finds better biopsy samples than conventional fluoroscopy-guided bronchoscopy in adults who need a lung biopsy for suspected interstitial lung disease.
-
Optimizing the diagnostic journey in interstitial lung disease
This trial tests whether bundling core tests and coordinating appointments can speed up diagnosis for adults referred with suspected interstitial lung disease.
-
JAK inhibitors versus calcineurin inhibitors as initial therapy for antisynthetase syndrome–associated ILD
This trial tests whether a JAK inhibitor or a calcineurin inhibitor, given with steroids, works better as the first treatment for antisynthetase syndrome–related interstitial lung disease in adults who haven’t been treated yet.
-
Inhaled L-menthol for breathlessness in interstitial lung disease
This trial will test whether inhaled L-menthol can reduce breathlessness and help adults with fibrosing interstitial lung disease exercise better.
-
Mosliciguat added to inhaled treprostinil for pulmonary hypertension from ILD
This trial tests whether adding inhaled mosliciguat to your inhaled treprostinil is safe and tolerable for people with pulmonary hypertension caused by interstitial lung disease.
-
Tetrandrine for lung disease linked to connective tissue disorders
This study tests whether tetrandrine tablets (60 mg three times daily), given with usual steroid or immunosuppressant treatment, can improve lung function in adults with connective tissue disease–related interstitial lung disease over 24 weeks.
-
Hypnosis for Breathlessness Mastery in People with Persistent Dyspnea
This study tests whether hypnosis can help people with persistent breathlessness from cancer, COPD, ILD, or heart failure feel more in control of their dyspnea.
-
Autologous Basal Layer Stem Cells for Interstitial Lung Disease
This study tests whether a patient’s own bronchial basal layer stem cells can be safely infused to help people with interstitial lung disease feel better or improve lung function.
-
Single-dose inhaled RJ026 in people with interstitial lung disease and healthy volunteers.
This trial will test whether a single inhaled dose of RJ026 is safe and how the body and lungs absorb and clear it in people with interstitial lung disease and in healthy volunteers.
-
AI-analyzed ECG to help find pulmonary hypertension in people with interstitial lung disease
This project tests whether an AI-read 12-lead ECG can help doctors find hidden pulmonary hypertension in adults with interstitial lung disease.
-
Home monitoring for patients with pulmonary fibrosis
This study tests if using home monitoring and video calls can help people with pulmonary fibrosis manage their condition as well as or better than regular clinic visits.
-
Screening for ASMD in people with diffuse interstitial lung disease
This study tests a screening algorithm to see if people with diffuse ILD, who may have ASMD, actually have the disease by measuring acid sphingomyelinase activity and LysoSM in a 200-person cohort.
-
Investigating the Role of Y Chromosome Mutations in Autoimmune Diseases
This study is trying to see how changes in the Y chromosome might affect the immune system and contribute to autoimmune diseases like Giant Cell Arteritis and Polymyalgia Rheumatica.
-
Early recognition and treatment strategies for fibrotic interstitial lung disease in China
This study is trying to find better ways to recognize and treat fibrotic interstitial lung disease in China by looking at a large group of patients and testing new methods for diagnosis and treatment.
-
Routine versus on-demand ECMO during lung transplant
This trial tests whether using ECMO routinely during lung transplant or only when needed leads to fewer complications for people having a lung transplant.
Related topics
Quick answers
How many Interstitial Lung Disease (ILD) clinical trials are recruiting right now?
21, as of November 12, 2026. 1 of them was first registered in the last 30 days. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 12 countries. The most sites are in China (5 trials), United Kingdom (3 trials), United States (2 trials), Spain (2 trials), Switzerland (2 trials). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1: 2, Phase 2: 2, Phase 4: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.